Jemincare

This study is testing whether a new targeted drug, JMKX001899, works better than standard chemotherapy (docetaxel) for people with advanced lung cancer that has a specific genetic change called KRAS G12C. The trial will involve about 472 adults whose cancer has worsened after pre…

This study is testing an investigational injection called JYB1904 for adults with chronic spontaneous urticaria, a condition causing long-lasting, itchy hives that are not well-controlled by standard allergy medications. The main goal is to see if the injection is better than a p…

This study is testing an investigational injection called JYB1904 to see if it can help control symptoms in adults with year-round allergic rhinitis. Participants will receive either the JYB1904 injection or a placebo (inactive) shot, in addition to their standard allergy medicat…

This early-stage study aims to understand how a new experimental drug for inherited kidney disease interacts with two existing medications (amiodarone for heart rhythm and febuxostat for gout). Researchers will give all three drugs to 48 healthy Chinese volunteers to measure how …

This early study aims to understand how the body absorbs, processes, and eliminates a potential new drug for a genetic kidney disease called ADPKD. It will involve 8 healthy male volunteers. Researchers will track how much of the drug gets into the bloodstream and how it leaves t…

This is an early safety study to see if a single dose of an experimental drug called JMKX003142 affects the heart's electrical rhythm in healthy people. The drug is being developed for a genetic kidney disease called ADPKD. Researchers will compare the drug's effects to a placebo…